Parkinson's Disease and pathological gambling: Results from a functional MRI study

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Movement Disorders

• Publication date

  2010-10-30

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1002/mds.23369PMID 20976739
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease

  2010cited by this paper
• Brain magnetic resonance imaging techniques in the diagnosis of parkinsonian syndromes.

  2010cited by this paper
• Fatigue in Parkinson's disease: Prevalence and associated factors

  2010cited by this paper
• Bilateral Deep Brain Stimulation vs Best Medical Therapy for Patients With Advanced Parkinson Disease: A Randomized Controlled Trial

  2009cited by this paper
• Towards an understanding of fatigue in Parkinson disease

  2009cited by this paper
• A reassessment of risks and benefits of dopamine agonists in Parkinson's disease.

  2009cited by this paper
• Pain in Parkinson’s disease: Prevalence and characteristics

  2009cited by this paper
• Brain activities associated with gaming urge of online gaming addiction.

  2009cited by this paper
• Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study.

  2009cited by this paper
• Fatigue in Japanese patients with Parkinson's disease: A study using Parkinson fatigue scale

  2009cited by this paper
• Mutation analysis for DJ-1 in sporadic and familial parkinsonism: screening strategy in parkinsonism.

  2009cited by this paper
• Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset

  2009cited by this paper
• Diagnostic guidelines for high‐resolution melting curve (HRM) analysis: An interlaboratory validation of BRCA1 mutation scanning using the 96‐well LightScanner™

  2009cited by this paper
• Reduced levodopa-induced complications after 5 years of subthalamic stimulation in Parkinson’s disease: a second honeymoon

  2009cited by this paper
• The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease

  2009cited by this paper
• Fatigue in levodopa-naïve subjects with Parkinson disease

  2008cited by this paper
• Is surgery recommended in adults with neglected congenital muscular torticollis? A prospective study

  2008cited by this paper
• Clinical and psychosocial factors associated with fatigue in patients with Parkinson's disease.

  2008cited by this paper
• MR imaging index for differentiation of progressive supranuclear palsy from Parkinson disease and the Parkinson variant of multiple system atrophy.

  2008cited by this paper
• Novel ATP13A2 variant associated with Parkinson disease in Taiwan and Singapore

  2008cited by this paper
• Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease

  2008cited by this paper
• Fatigue in Parkinson's disease is not related to excessive sleepiness or quality of sleep.

  2008cited by this paper
• Mutation analysis of the PINK1 gene in 391 patients with Parkinson disease.

  2008cited by this paper
• PARK9-LINKED PARKINSONISM IN EASTERN ASIA: MUTATION DETECTION IN ATP13A2 AND CLINICAL PHENOTYPE

  2008cited by this paper
• Functional abnormalities underlying pathological gambling in Parkinson disease.

  2008cited by this paper
• Fatigue in Parkinson's disease: A review

  2007cited by this paper
• Factors associated with dopaminergic drug-related pathological gambling in Parkinson disease.

  2007cited by this paper
• Leucine-Rich Repeat kinase 2 G2385R variant is a risk factor for Parkinson disease in Asian population

  2007cited by this paper
• [Torticollis in children: diagnostic approach].

  2007cited by this paper
• Methylphenidate improves fatigue scores in Parkinson disease: A randomized controlled trial

  2007cited by this paper
• Pathological gambling in Parkinson's disease: Risk factors and differences from dopamine dysregulation. An analysis of published case series

  2007cited by this paper
• Levodopa response in long‐term bilateral subthalamic stimulation for Parkinson's disease

  2007cited by this paper
• Brain substrates of craving to alcohol cues in subjects with alcohol use disorder.

  2007cited by this paper
• ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease

  2007cited by this paper
• MR imaging of middle cerebellar peduncle width: differentiation of multiple system atrophy from Parkinson disease.

  2006cited by this paper
• The use of fluoroquinolones in children

  2006cited by this paper
• Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase

  2006cited by this paper
• A common missense variant in the LRRK2 gene, Gly2385Arg, associated with Parkinson’s disease risk in Taiwan

  2006cited by this paper
• Botulinum toxin injection for congenital muscular torticollis presenting in children and adults

  2006cited by this paper
• Should addictive disorders include non-substance-related conditions?

  2006cited by this paper
• Subthalamic nucleus deep brain stimulation: Summary and meta‐analysis of outcomes

  2006cited by this paper
• Multiple candidate gene analysis identifies alpha-synuclein as a susceptibility gene for sporadic Parkinson's disease.

  2006cited by this paper
• A randomized trial of deep-brain stimulation for Parkinson's disease.

  2006cited by this paper
• Clinical heterogeneity of alpha-synuclein gene duplication in Parkinson's disease.

  2006cited by this paper
• Evolution of Parkinson's disease during 4 years of bilateral deep brain stimulation of the subthalamic nucleus

  2006cited by this paper
• Penguins and hummingbirds: Midbrain atrophy in progressive supranuclear palsy

  2006influential reference
• Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries

  2006cited by this paper
• High-resolution DNA melting analysis for simultaneous mutation scanning and genotyping in solution.

  2005cited by this paper
• Pathological gambling is linked to reduced activation of the mesolimbic reward system

  2005cited by this paper
• Stimulation of the subthalamic nucleus in Parkinson’s disease: a 5 year follow up

  2005cited by this paper
• Quantitative MRI measurement of superior cerebellar peduncle in progressive supranuclear palsy

  2005influential reference
• Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.

  2005cited by this paper
• Botulinum Toxin Type A in the Treatment of Children with Congenital Muscular Torticollis

  2005cited by this paper
• New and reliable MRI diagnosis for progressive supranuclear palsy

  2005influential reference
• A Novel Method for Measuring and Monitoring Monobloc Distraction Osteogenesis Using Three-Dimensional Computed Tomography Rendered Images With the ‘Biporion-Dorsum Sellae’ Plane. Part I: Precision and Reproducibility

  2005cited by this paper
• Facial scoliosis from sternocleidomastoid torticollis: long-term postoperative evaluation.

  2005cited by this paper
• Cue-induced brain activity in pathological gamblers.

  2005cited by this paper
• Efficacy of deep brain stimulation of the subthalamic nucleus in Parkinson’s disease 4 years after surgery: double blind and open label evaluation

  2004cited by this paper
• Sleep and fatigue in Parkinson's disease.

  2004cited by this paper
• Switching from ergot to nonergot dopamine agonists in Parkinson's disease: A clinical series and five‐drug dose conversion table

  2004cited by this paper
• Is fatigue an independent and persistent symptom in patients with Parkinson disease?

  2004cited by this paper
• Mutations in the glucocerebrosidase gene and Parkinson's disease in Ashkenazi Jews.

  2004cited by this paper
• Craniofacial Deformity in Patients with Uncorrected Congenital Muscular Torticollis: An Assessment from Three-Dimensional Computed Tomography Imaging

  2004cited by this paper
• Levodopa improves physical fatigue in Parkinson's disease: A double‐blind, placebo‐controlled, crossover study

  2003cited by this paper
• Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.

  2003cited by this paper
• SIC Task Force appraisal of clinical diagnostic criteria for parkinsonian disorders

  2003cited by this paper
• Measuring fatigue in patients with Parkinson's disease – the Fatigue Severity Scale

  2002cited by this paper
• The Parkinson’s disease sleep scale: a new instrument for assessing sleep and nocturnal disability in Parkinson’s disease

  2002cited by this paper
• Exacerbated physical fatigue and mental fatigue in Parkinson's disease

  2001cited by this paper
• Measurement of the midbrain diameter on routine magnetic resonance imaging: a simple and accurate method of differentiating between Parkinson disease and progressive supranuclear palsy.

  2001cited by this paper
• Functional magnetic resonance imaging of cocaine craving.

  2001influential reference
• Comorbidity of the nonmotor symptoms of Parkinson's disease

  2001cited by this paper
• Clinical Determinants of the Outcome of Manual Stretching in the Treatment of Congenital Muscular Torticollis in Infants: A Prospective Study of Eight Hundred and Twenty-one Cases

  2001cited by this paper
• Congenital Muscular Torticollis and the Associated Craniofacial Changes

  2000cited by this paper
• A brief cognitive test battery to differentiate Alzheimer's disease and frontotemporal dementia

  2000cited by this paper
• The clinical presentation and outcome of treatment of congenital muscular torticollis in infants--a study of 1,086 cases.

  2000cited by this paper
• Fatigue in patients with Parkinson's disease

  1999cited by this paper
• Diagnostic criteria for Parkinson disease.

  1999cited by this paper
• Fatigue in the general Norwegian population: normative data and associations.

  1998cited by this paper
• Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

  1998cited by this paper
• Relationship between brainstem MRI and pathological findings in progressive supranuclear palsy--study in autopsy cases.

  1997influential reference
• The prevalence of nonmuscular causes of torticollis in children.

  1996cited by this paper
• Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome)

  1996cited by this paper
• The epidemiology of Parkinson's disease in the county of Rogaland, Norway

  1995cited by this paper
• Analysis of fMRI time-series revisited.

  1995cited by this paper
• The SF-36 Health Survey: Development and use in mental-health research and the IQOLA project

  1994cited by this paper
• The MOS 36‐Item Short‐Form Health Survey (SF‐36): II. Psychometric and Clinical Tests of Validity in Measuring Physical and Mental Health Constructs

  1993cited by this paper
• Development of a fatigue scale.

  1993cited by this paper
• Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

  1992cited by this paper
• Core assessment program for intracerebral transplantations (CAPIT)

  1992cited by this paper
• The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

  1988cited by this paper
• Recent Developments in Parkinson's Disease

  1986cited by this paper
• “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician

  1975cited by this paper
• Parkinsonism

  1967cited by this paper
• An inventory for measuring depression.

  1961cited by this paper
• Access to the Published Version May Require Journal Subscription. Published with Permission From: Elsevier Measuring Fatigue in Parkinson's Disease: a Psychometric Study of Two Brief Generic Fatigue Questionnaires

  year unknowncited by this paper

• Serotonergic cortico-limbic and executive network dysfunction in Parkinson's disease impulse control disorders: a PET-fMRI study.

  2026cites this paper
• Neuroimaging Advances in Neuropsychiatric Symptoms Associated with Parkinson’s Disease

  2025cites this paper
• Neural network localization in Parkinson’s disease with impulse control disorders

  2025cites this paper
• Imaging of impulse control disorders in Parkinson's disease.

  2024cites this paper
• Meta-analysis of structural and functional abnormalities in behavioral addictions.

  2024cites this paper
• Neural correlates of risky decision making in Parkinson’s disease patients with impulse control disorders

  2022cites this paper
• Dropout or Early Treatment Response Among Gamblers with Depressive Symptoms

  2022cites this paper
• Exploring brain changes of impulse control disorders in Parkinson's disease: An ALE study

  2022cites this paper
• Network Pharmacology and Molecular Docking-Based Prediction of the Molecular Targets and Signaling Pathways of Ginseng in the Treatment of Parkinson's Disease

  2022influential citation
• Aberrant Salient and Corticolimbic Connectivity in Hypersexual Parkinson's Disease

  2021cites this paper
• Abnormal Topological Network in Parkinson’s Disease With Impulse Control Disorders: A Resting-State Functional Magnetic Resonance Imaging Study

  2021influential citation
• Imaging Cognitive Impairment and Impulse Control Disorders in Parkinson's Disease

  2021cites this paper
• Incentive-driven decision-making networks in de novo and drug-treated Parkinson's disease patients with impulsive-compulsive behaviors: A systematic review of neuroimaging studies.

  2020cites this paper
• From apathy to addiction: Insights from neurology and psychiatry.

  2020cites this paper
• MRI of Motor and Nonmotor Therapy‐Induced Complications in Parkinson's Disease

  2020cites this paper
• Functional Inhibitory Control Dynamics in Impulse Control Disorders in Parkinson's Disease

  2019cites this paper
• Resting state oscillations suggest a motor component of Parkinson's Impulse Control Disorders.

  2019cites this paper
• Impulse Control Disorders in REM Sleep Behavior Disorder

  2019cites this paper
• Impulse control disorders in Parkinson's disease: A 20‐year odyssey

  2019cites this paper
• Functional imaging studies of Impulse Control Disorders in Parkinson's disease need a stronger neurocognitive footing

  2019cites this paper
• Neural bases of Impulse Control Disorders in Parkinson's disease: a systematic review and an ALE meta-analysis.

  2019cites this paper
• Neurocognitive correlates of medication-induced addictive behaviours in Parkinson's disease: A systematic review.

  2018cites this paper
• White Matter Tract Alterations in Drug-Naïve Parkinson’s Disease Patients With Impulse Control Disorders

  2018cites this paper
• Brain PET substrate of impulse control disorders in Parkinson's disease: A metabolic connectivity study

  2018cites this paper
• Disruption of Multiple Distinctive Neural Networks Associated With Impulse Control Disorder in Parkinson's Disease

  2018cites this paper
• The neurobiology of impulse control disorders in Parkinson’s disease: from neurotransmitters to neural networks

  2018cites this paper
• Decision-Making and Impulse Control Disorders in Parkinson's Disease

  2017cites this paper
• Imaging behavioural complications of Parkinson’s disease

  2017cites this paper
• Pedestrian safety in patients with Parkinson's disease: A case‐control study

  2017cites this paper
• Impulse Control and Related Disorders in Parkinson's Disease.

  2017cites this paper
• Effect of Levodopa on Reward and Impulsivity in a Rat Model of Parkinson’s Disease

  2017cites this paper
• Resting-state brain networks in patients with Parkinson's disease and impulse control disorders.

  2017cites this paper
• Intrinsic brain connectivity predicts impulse control disorders in patients with Parkinson's disease

  2017cites this paper
• Impulse Control Behavior in Movement Disorders: Focus on Restless Leg Syndrome

  2017cites this paper
• Impulse control disorders and dyskinesias in Parkinson’s disease : an update

  2016cites this paper
• Trait Impulsivity and Anhedonia: Two Gateways for the Development of Impulse Control Disorders in Parkinson’s Disease?

  2016cites this paper
• A review of adverse events linked to dopamine agonists in the treatment of Parkinson’s disease

  2016cites this paper
• Impulse Control Disorders

  2015cites this paper
• Rodent models of impulsive-compulsive behaviors in Parkinson's disease: How far have we reached?

  2015cites this paper
• Magnetic Resonance Techniques Applied to the Diagnosis and Treatment of Parkinson’s Disease

  2015cites this paper
• Dyskinesias and impulse control disorders in Parkinson's disease: From pathogenesis to potential therapeutic approaches.

  2015cites this paper
• Mesolimbic Dopaminergic Neural Changes in Relation to the Impulsive Compulsive Behaviors in patients with Parkinson's disease

  2014cites this paper
• Depression and impulse control disorders in Parkinson's disease: two sides of the same coin?

  2014cites this paper
• Cortical volume and folding abnormalities in Parkinson's disease patients with pathological gambling.

  2014cites this paper
• Impulsive and compulsive behaviors in Parkinson's disease.

  2014cites this paper
• The role of dopamine in risk taking: a specific look at Parkinson’s disease and gambling

  2014cites this paper
• Parkinson's disease: in vivo metabolic changes in the frontal and parietal cortices in 6-OHDA treated rats during different periods

  2014cites this paper
• Should impulse control disorders and dopamine dysregulation syndrome be indications for deep brain stimulation and intestinal levodopa?

  2013cites this paper
• Expanding the spectrum of impulse control disorders in Parkinson ' s disease : the phenomenology of sweet craving

  2013cites this paper
• Combinaison des approches psychopharmacologiques et d'imagerie cérébrale pour l’étude de la prise de décision individuelle et sociale chez l’Homme

  2013cites this paper
• Parkinson-Syndrom, Chorea Huntington

  2013cites this paper
• Attenuated neural response to gamble outcomes in drug-naive patients with Parkinson's disease.

  2013cites this paper
• Impulsivity and apathy in Parkinson's disease.

  2013cites this paper
• A Systematic Review of Impulse Control Disorders in Parkinson's Disease

  2013influential citation
• An update on impulse control disorders in Parkinson's disease

  2012cites this paper
• Psychiatry of Parkinson’s Disease

  2012cites this paper
• Dopamine's role in risk taking: a specific look at dopamine deficiency and gambling

  2012cites this paper
• Impulse Control and Related Disorders in Parkinson’s Disease

  2012cites this paper
• Increased medial orbitofrontal [18F]fluorodopa uptake in Parkinsonian impulse control disorders

  2012cites this paper
• Pathological behaviors provoked by dopamine agonist therapy of Parkinson's disease.

  2011cites this paper
• Pathological gambling in Parkinson's disease—a review of the literature

  2011cites this paper
• Impulsivity and Parkinson's disease: more than just disinhibition.

  2011cites this paper
• Cue-induced striatal dopamine release in Parkinson's disease-associated impulsive-compulsive behaviours.

  2011cites this paper
• Impulse control disorders in Parkinson's disease: recent advances.

  2011cites this paper
• Similarities and differences between pathological gambling and substance use disorders: a focus on impulsivity and compulsivity

  2011cites this paper
• Clinical aspects of impulsive compulsive behaviours in Parkinson's disease.

  2011cites this paper